E3-Hormone Refractory Prostrate Cancer Taxotere Combination

Clinical trial NCT00498797 · COMPLETED

Trial details

NCT number: NCT00498797
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic Hormone Refractory

Start date: 2005-12-01
Primary completion: 2007-07-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.